Cerity Partners LLC lifted its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 65.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 27,090 shares of the medical research company’s stock after acquiring an additional 10,761 shares during the period. Cerity Partners LLC’s holdings […] - 2025-04-18 08:00:55
Alliancebernstein L.P. lowered its stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 92.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 69,845 shares of the medical research company’s stock after selling 890,747 shares during the quarter. Alliancebernstein L.P.’s holdings in Exact […] - 2025-04-15 07:50:49
CIBC Private Wealth Group LLC lowered its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 11.3% during the fourth quarter, HoldingsChannel.com reports. The fund owned 3,357 shares of the medical research company’s stock after selling 426 shares during the quarter. CIBC Private Wealth Group LLC’s holdings in Exact Sciences were worth $190,000 at […] - 2025-04-07 08:04:59
Mitsubishi UFJ Trust & Banking Corp cut its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 1.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 80,058 shares of the medical research company’s stock after selling […] - 2025-03-31 08:40:55
Corient Private Wealth LLC trimmed its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 40.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,813 shares of the medical research company’s stock after selling 13,018 shares during the period. […] - 2025-03-27 08:42:59
Intech Investment Management LLC reduced its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 70.3% during the 4th quarter, Holdings Channel reports. The fund owned 3,560 shares of the medical research company’s stock after selling 8,426 shares during the period. Intech Investment Management LLC’s holdings in Exact Sciences were worth $200,000 as of […] - 2025-03-27 08:03:08
Shares of Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) have been given a consensus rating of “Moderate Buy” by the twenty research firms that are covering the stock, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and eighteen have assigned a buy recommendation to the company. The average 1-year […] - 2025-03-24 06:08:55
M&T Bank Corp lowered its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 14.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,963 shares of the medical research company’s stock after selling 1,293 shares during the period. M&T Bank […] - 2025-03-14 08:08:55
SBI Securities Co. Ltd. bought a new stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 1,183 shares of the medical research company’s stock, valued at approximately $66,000. A number of other large investors […] - 2025-03-10 07:46:54
Proficio Capital Partners LLC purchased a new stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm purchased 28,545 shares of the medical research company’s stock, valued at approximately $1,604,000. A number of other institutional investors and hedge funds have […] - 2025-03-07 09:26:49
Private Advisor Group LLC lowered its stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.0% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 22,796 shares of the medical research company’s stock after selling 2,253 shares during the quarter. Private Advisor Group […] - 2025-02-28 09:15:01
First Horizon Advisors Inc. decreased its stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 20.3% during the 4th quarter, HoldingsChannel.com reports. The fund owned 1,970 shares of the medical research company’s stock after selling 502 shares during the period. First Horizon Advisors Inc.’s holdings in Exact Sciences were worth $111,000 as of its […] - 2025-02-27 09:05:00
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) shares traded up 4.8% during mid-day trading on Monday after Scotiabank raised their price target on the stock from $70.00 to $73.00. Scotiabank currently has a sector outperform rating on the stock. Exact Sciences traded as high as $51.50 and last traded at $51.64. 762,199 shares changed […] - 2025-02-25 06:04:51
CIBC Asset Management Inc raised its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 14.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,396 shares of the medical research company’s stock after acquiring an additional 907 shares […] - 2025-02-24 10:06:54
Rhumbline Advisers lowered its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 2.7% during the fourth quarter, Holdings Channel reports. The institutional investor owned 217,428 shares of the medical research company’s stock after selling 5,997 shares during the quarter. Rhumbline Advisers’ holdings in Exact Sciences were worth $12,217,000 as of its […] - 2025-02-24 09:04:55
Principal Financial Group Inc. cut its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 22.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 808,515 shares of the medical research company’s stock after selling 240,741 shares during the period. Principal Financial Group Inc. owned 0.44% […] - 2025-02-21 09:49:09
Van ECK Associates Corp trimmed its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 122,842 shares of the medical research company’s stock after selling 13,023 shares during the […] - 2025-02-18 08:36:53
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) has been given an average rating of “Moderate Buy” by the nineteen research firms that are currently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold rating and eighteen have issued a buy rating on the company. The average 1 year price […] - 2025-02-05 06:38:52
Exchange Traded Concepts LLC reduced its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 6.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 11,669 shares of the medical research company’s stock after selling 843 shares during the period. Exchange Traded Concepts LLC’s holdings in […] - 2025-01-30 08:53:03
EXAS institutional holdings
The following institutional investment holdings of EXAS have been identified
Date
ETF ISIN/Name
Num Shares
Book value
Fatal error: Uncaught mysqli_sql_exception: Column 'Currency_Code' in field list is ambiguous in /var/www/liquidata/show_aggregate_holdings.php:119
Stack trace:
#0 /var/www/liquidata/show_aggregate_holdings.php(119): mysqli->query()
#1 {main}
thrown in /var/www/liquidata/show_aggregate_holdings.php on line 119